Additional information
White Powder
1371615-56-3
ACI-011206
120-123°C
C40H47FN3NaO8
739.82
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
Sodium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate
Sodium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate
Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide Sodium Salt





![DESACETYL PALBOCICLIB HYDROCHLORIDE (25 mg) (8-Cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (1:1))](https://staging.analyticachemie.in/wp-content/uploads/uspimage-1.jpg)